Biotech

Medivation and Astellas Announce Initiation of Expanded Access Program for Enzalutamide (formerly MDV3100) in the United States

SAN FRANCISCO, CA and TOKYO: Now Enrolling Men With Metastatic Prostate Cancer Previously Treated With Chemotherapy ...

MethylGene to Present MGCD265 Data at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting

MONTREAL, CANADA: ...

CDRD and CDRD Ventures Inc. Enter into a Collaboration with GSK to Advance the Development and Commercialization of Canadian Health Research

VANCOUVER, CANADA: ...

Paladin Labs Inc. Names Jonathan Ross Goodman as Chairman of the Board of Directors

MONTREAL, CANADA: ...

Immunovaccine Announces Results of 2012 Annual General Meeting

HALIFAX, NOVA SCOTIA: ...

Paladin Labs and Nuvo Research Sign Canadian License Agreement for Synera and a Loan Agreement

MONTREAL, QUEBEC and MISSISSAUGA, ONTARIO: ...

Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2012

HALIFAX, NOVA SCOTIA: - New vaccine collaborations in infectious diseases and cocaine addiction validate the promise of Immunovaccine's technologies - Successful private placement raises $2.8 million ...

Cytokinetics Announces Opening of Second Cohort in Phase IIb Clinical Trial of Intravenous Omecamtiv Mecarbil in Patients With Acute Heart Failure

SOUTH SAN FRANCISCO, CA: Independent Data Monitoring Committee Recommends Progression to Second Cohort ...

MethylGene to Present at BioFinance 2012 Conference

MONTREAL, CANADA: ...

IBEX Reports Update on JF Gareau/Garvinci Lawsuit

MONTREAL, QUEBEC: Quebec Superior Court Allows IBEX Claim to Proceed/Trial Date Set for April 2014 ...